Category: Drug Discovery
North America Drug Discovery
-
Global Axial Spondyloarthritis Market, By Commercialized Therapies (Anti-Tumour Necrosis Factor Therapy(TNF),Anti-Interleukin Therapy(IL), Anti-Janus Kinase Therapy(JAK)); By Potential Pipeline Products (Anti-Janus Kinase Therapy(JAK), Anti-Interleukin (IL)-17 Therapy, Other) ;By Indication(Ankylosing Spondylitis, Non-Radiographic Axial Spondylitis); By Region (North America, Europe, The Asia Pacific, Latin America, The Middle East, and Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028.
... America, Europe, The Asia Pacific, Latin America, The Middle East, and Africa); Trend Analysis, Competitive Market Share & Forecast, 2018-2028. Global Axial Spondyloarthritis Market to Reach USD 4.95 Billion by 2028 The growth of the ... Read More
-
North America Compound Management Market Size, Share & Industry Trends Analysis Report By Type, By Application, By Sample Type (Chemical Compounds and Bio Samples), By End User, By Country and Growth Forecast, 2022 - 2028
... The North America Compound Management Market would witness market growth of 14.2% CAGR during the forecast period (2022-2028). The market is anticipated to grow as a result of businesses working together and utilizing expertise more ... Read More
-
United States Anticoagulation Therapy Market, By Product Type (Drugs (Novel Oral Anticoagulants (NOAC’s), Warfarin (VKA)), (PT/INR Testing Devices (In-Office Testing Devices, Analyzers, Reagents and Kits, Home Testing Devices), Service (Testing Services and Consulting Services), By Clinic (Hospital Associated Clinic, Independent Clinics, and Pharmacy-Based Clinics) Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Clinic (Hospital Associated Clinic, Independent Clinics, and Pharmacy-Based Clinics) Trend Analysis, Competitive Market Share & Forecast, 2018-2028 US Anticoagulation Therapy Market to Grow at a CAGR of 7.9% until 2028 United States Anticoagulation Therapy Market ... Read More
-
ENT Disorder Treatment Market, by Treatment Type (Devices (Hearing Aid Devices, Voice Prosthesis, Nasal Splints, Hearing Implants and Others) and Drug Type (Antibiotics, Antihistamines, Steroids, Anti-inflammatory Drugs, Others)), by Organ Type (Ear, Nose, and Throat), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... by End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 ... Read More
-
Recombinant DNA Technology Market, by Product Type (Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy and Gene Editing), by Application (Therapeutics, Agriculture, and Research), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 Recombinant DNA (rDNA) technology is a novel technique that has led to advances in a number of ... Read More
-
Next Generation Sequencing Market, by Technology (Whole Genome Sequencing, Whole Exome Sequencing, RNA Sequencing, Targeted Re-sequencing, and Others), by Application (Drug Discovery, Personalized Medicine and Genetic Screening, Disease Diagnosis, Agriculture and Animal Research, and Others), by End User (Hospital, Research Centers, Pharma and Biotech Firms, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... by End User (Hospital, Research Centers, Pharma and Biotech Firms, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - ... Read More
-
Biopharmaceutical and Biomedicine Market, by Product Type (Biopharmaceutical (Monoclonal Antibodies, Vaccines, Recombinant Human Insulin, Human Growth Hormone, Erythropoietin, Interferon, Colony Stimulating Factor, Blood Factors, Fusion Protein, and Others), Nanomedicine, Cell & Gene Therapy, Bioinformatics, and Molecular Enzymes & Kits), by Application (Therapeutics, Diagnostics, and Research and Development), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Molecular Enzymes & Kits), by Application (Therapeutics, Diagnostics, and Research and Development), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - ... Read More
-
Tuberculosis Drugs Market, by Therapy Type (First Line Therapy, and Second Line Therapy), by Disease type (Active TB, and Latent TB), by End User (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and by Region (North America, Latin America, Europe, As
... Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Tuberculosis is a common infectious disease caused by mycobacterium tuberculosis that affects the lungs. The treatment ... Read More
-
U.S. Contract Research Organization (CROs) Market, by Service Type (Drug Discovery, Preclinical studies, Early Phase I – IIa, Phase IIa – III, Phase IIIb – IV, Drug Development, Medical Coding and Writing, Monitoring, Clinical Data Management, Bio-statist
... Management, Bio-statistics, Site Management, Protocol Development, and Biomarker Discovery), by Therapeutic Application (Oncology, Cardiovascular Diseases, Central Nervous System Diseases, Infectious Diseases, Metabolic Disorders, Immunological Disorders, Respiratory Disorders, and Others), and by Size of CRO (Small ... Read More
-
Hepatitis C Drugs Market, by Drug Type (Interferon Based Therapies, NS5A Inhibitors, NS5B Inhibitors, and Protease Inhibitors), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin A
... Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Hepatitis C virus is a blood-borne virus that infects liver cells, resulting in illness that ranges from mild and ... Read More
-
Biopreservation Market, By Product Type (Equipment (Freezers, Refrigerators, Liquid Nitrogen Tanks, Consumables), LIMS, Media (Home-brew, Pre-formulated)), By Application (Regenerative Medicine, Biobanking, Drug Discovery), and By Region (North America, L
... & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Biopreservation is the technique that aids in the preservation of bio specimens such as saliva, plasma, and purified DNA. This technique primarily increases ... Read More
-
U.S. Biochip Product & Services Market, By Type (Products (Microarrays, Reagents & other Consumables, Others), Services), By Application (Drug Discovery, Life Science Research, IVD Tests, Others) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 20
... 2028 Surgical Equipment are used for diagnosis of infectious diseases, respiratory diseases, cancer, and for personalized treatment. There are three types of biochips namely DNA microarray, protein microarray, and microfluidic chip. Increasing number of clinical ... Read More
-
3D Cell Culture Market, by Technology (Extracellular Matrices or Scaffolds, Bioreactors, Gels, Scaffold-free Platforms, and Microchips), by Application (Research, Drug Discovery, Tissue Engineering, Clinical Applications, and Stem Cell Biology), by End Us
... Institutes, Biopharmaceutical Industry, Hospitals And Diagnostic Centers, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 A 3D ... Read More
-
North America Pharmacogenomics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (PCR, Sequencing, Microarray, Gel Electrophoresis, Mass Spectrometry, and Others), Application (Drug Discovery, Oncology, Neurology and Psychiatry, Pain Management, Cardiovascular Diseases, and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others)
... and Others), and End User (Hospitals and Clinics, Biopharmaceutical Companies, CROs and CDMOs, and Others) The North America pharmacogenomics market is expected to reach US$ 6,534.83 million by 2028 from US$ 3,333.43 million in 2021. ... Read More
-
North America Cystic Fibrosis Therapeutics Market Databank
... 2021 to 2029. Hospital segment is expected to be the highest contributor to this market, with $3,622.8 Million in 2020, and is anticipated to reach $4,436.7 Million by 2029, registering a CAGR of 2.32%. Retail ... Read More
-
United States Drug Discovery Market Forecast 2022-2028
... drug discovery and development markets with the presence of several industry players. MARKET INSIGHTS In the United States, cancer and heart disease have been leading death causes for over a decade. Also, the rising prevalence ... Read More
-
North America Drug Discovery Market Forecast 2022-2030
... growing prioritization of several therapeutic areas like rare diseases and women’s health. REGIONAL INSIGHTS The United States and Canada are assessed for the North America drug discovery market growth analysis. In Canada, the drug discovery ... Read More
-
Global Autoimmune Disease Therapeutics Market: Analysis By Drug Class (Anti-inflammatory, Interferons, NSAIDs and Antihyperglycemics) By Indication (Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Disease, Type 1 Diabetes) By Region (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America) Size & Trends with Impact of Covid-19 and Forecast up to 2025
... & Africa, and Latin America) Size & Trends with Impact of Covid-19 and Forecast up to 2025 Scope of the Report The report provides an in depth analysis of the global autoimmune disease therapeutics market ... Read More
-
North America Genome Editing Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Technology (CRISPR, TALEN, Antisense, and Other), Application (Cell Line Engineering, Genetic Engineering, Diagnostic Applications, Drug Discovery, and Others), and End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations)
... User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Clinical Research Organizations) The genome editing market in North America is expected to grow from US$ 2,136.41 million in 2021 to US$ 7,024.71 million by ... Read More
-
North America Lymphedema Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Condition Type (Primary Lymphedema and Secondary Lymphedema), Treatment Type (Laser Therapy, Compression Devices and Bandaging, Drug Therapy, Physiological Procedures {Lymphovenous Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others)
... Anastomosis (LVA) and Vascularized Lymph Node Transfer (VLNT)}, Debulking Procedures {Surgical Debulking, Liposuction, and Others}, and Others), and End User (Hospitals, Clinics, Clinical Research Organizations, and Others) The lymphedema treatment market in North America is ... Read More
-
Global and United States CRM197 Market Report & Forecast 2022-2028
... data of other regions in regional level and county level. Due to the COVID-19 pandemic, the global CRM197 market size is estimated to be worth US$ 177.06 million in 2022 and is forecast to a ... Read More
-
United States Pain Management Therapeutics Market, Forecast 2022-2028, Industry Trends, Outlooks, Impact of COVID-19, Company Analysis
... has faced a crisis in the United States for years due to severe problems accessing sufficient care, resulting in considerable physical, emotional, and societal expenses. To treat pain caused by inflammation in reaction to tissue ... Read More
-
North America Benign Prostatic Hyperplasia Therapeutics Market Size, Share & Industry Trends Analysis Report By Therapy (Mono Drug Therapy and Combination Drug Therapy), By Therapeutics Class, By Country and Growth Forecast, 2021 - 2027
... North America Benign Prostatic Hyperplasia Therapeutics Market would witness market growth of 3.4% CAGR during the forecast period (2021-2027). The condition in which the prostate and surrounding tissue enlarge, it is known as benign prostatic ... Read More
-
Blood Based Biomarker Market, By Type (Screening Biomarker, Diagnosis Biomarker, and Others), By Disease (Cancer, Neurological Disorders, and Others), By Application (Diagnostics, Drug Discovery, and Personalized Medicine), and By Region (North America, Latin America, Europe, Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Asia-Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 The term biomarker, or biological marker, refers to a broad range of measures that capture what is happening in a ... Read More
-
Chronic Liver Diseases Therapeutics Market, by Treatment Type (Antiviral Drugs, Immunosuppressant’s, Vaccines, Immunoglobulin’s, Corticosteroids, Targeted Therapy, and Chemotherapy), by Disease Type (Hepatitis, Autoimmune Diseases, Non-alcoholic Fatty Liver Disease (NAFLD), Cancer, Genetic Disorders, and Others), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030 The liver ... Read More
Research Assistance
